Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share (Details) - Schedule of diluted net loss per share

v3.20.2
Net Loss Per Share (Details) - Schedule of diluted net loss per share - shares
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total common stock equivalents 1,650,511 384,647
Stock Options [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total common stock equivalents 338,595 188,595
Warrant [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total common stock equivalents 1,311,916 196,052